Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001133796-02-000045
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR YEAR ENDING 12/31/2001 k20301_10-k.htm 10-K 533099
3 GRAPHIC graph.jpg GRAPHIC 23869
4 SUBSIDIARY OF THE REGISTRANT k20301ex21.htm EX-21.1 496
5 CONSENT OF ARTHUR ANDERSEN LLP k20301ex23_1.htm EX-23.1 946
6 LETTER TO S.E.C. REGARDING ARTHUR ANDERSEN LLP k20301ex99.htm EX-99.1 1472
  Complete submission text file 0001133796-02-000045.txt   561873
Mailing Address 5935 DARWIN COURT CARLSBAD CA 92008
Business Address 5935 DARWIN COURT CARLSBAD CA 92008 6194317080
IMMUNE RESPONSE CORP (Filer) CIK: 0000817785 (see all company filings)

EIN.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-18006 | Film No.: 02597806
SIC: 2836 Biological Products, (No Diagnostic Substances)